Literature DB >> 10817281

Milk-borne insulin with trypsin inhibitor in milk induces pancreatic amylase development at the onset of weaning in rats.

T Kinouchi1, K Koizumi, T Kuwata, T Yajima.   

Abstract

BACKGROUND: The physiologic significance of milk-borne hormones and growth factors for internal organs of suckling animals is poorly understood. In this study the significance of milk-borne insulin was evaluated, as well as its combination with trypsin inhibitor, and its role in the development of pancreatic digestive capacity at the time of weaning was investigated.
METHODS: Experiments were performed using insulin-deficient milk formula (standard formula), insulin (20 ng/ml) formula, or insulin with trypsin inhibitor (1 U/ml) formula by a rat artificial-rearing technique.
RESULTS: In 17-day-old rats administered standard formula, the plasma insulin level was as low as that in 14-day-old rats. When insulin-trypsin inhibitor formula was administered to rat pups, the plasma insulin level was significantly higher than those in rats given standard or insulin formula. In rats artificially reared on standard formula, the usual developmental increases in pancreatic amylase activity and plasma insulin concentration at the beginning of weaning did not occur. Insulin formula elevated the pups' plasma insulin concentration and amylase activity at the onset of weaning but not to the levels observed in mother-reared rats. In rats reared on insulin-trypsin inhibitor formula, the developmental increases in the plasma insulin concentration and amylase activity observed in mother-reared rats were induced.
CONCLUSIONS: The present study demonstrates the necessity of milk-borne insulin for the development of pancreatic amylase during the weaning period.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817281     DOI: 10.1097/00005176-200005000-00010

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Intestinal and systemic effects of oral insulin supplementation in rats after weaning.

Authors:  Raanan Shamir; Muhamed Muslach; Igor Sukhotnik; Rina Perlman; Eric Diamond; Jorge Mogilner; Naim Shehadeh
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

2.  Adiponectin, leptin and insulin in breast milk: associations with maternal characteristics and infant body composition in the first year of life.

Authors:  D Chan; S Goruk; A B Becker; P Subbarao; P J Mandhane; S E Turvey; D Lefebvre; M R Sears; C J Field; M B Azad
Journal:  Int J Obes (Lond)       Date:  2017-08-14       Impact factor: 5.095

3.  Insulin in human milk: postpartum changes and effect of gestational age.

Authors:  N Shehadeh; E Khaesh-Goldberg; R Shamir; R Perlman; P Sujov; A Tamir; I R Makhoul
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

4.  Analysis of insulin in human breast milk in mothers with type 1 and type 2 diabetes mellitus.

Authors:  T J Whitmore; N J Trengove; D F Graham; P E Hartmann
Journal:  Int J Endocrinol       Date:  2012-03-05       Impact factor: 3.257

5.  Human Milk Cells Contain Numerous miRNAs that May Change with Milk Removal and Regulate Multiple Physiological Processes.

Authors:  Mohammed Alsaweed; Ching Tat Lai; Peter E Hartmann; Donna T Geddes; Foteini Kakulas
Journal:  Int J Mol Sci       Date:  2016-06-17       Impact factor: 5.923

Review 6.  Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects.

Authors:  Ma'mon M Hatmal; Mohammad A I Al-Hatamleh; Amin N Olaimat; Walhan Alshaer; Hanan Hasan; Khaled A Albakri; Enas Alkhafaji; Nada N Issa; Murad A Al-Holy; Salim M Abderrahman; Atiyeh M Abdallah; Rohimah Mohamud
Journal:  Biomedicines       Date:  2022-05-24

7.  The control of hyperglycemia by a novel trypsin resistant oral insulin preparation in alloxan induced type I diabetic mice.

Authors:  Sarbashri Bank; Arjun Ghosh; Suman Bhattacharya; Smarajit Maiti; Gausal A Khan; Asru K Sinha
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.